HCA Healthcare Reports $19.2B Q3 Revenue 29% Increase Across 20 States UK

HCA Healthcare reported strong financial results for the third quarter and nine months ending September 30, 2025, with third-quarter sales reaching $19.16 billion and net income rising to $1.64 billion, reflecting significant year-over-year growth. The company's non-GAAP earnings per share of $6.96 exceeded analyst estimates by $1.23, marking a 23.19% earnings surprise and contributing to a 2% increase in shares during pre-market trading. Same-facility admissions grew 2.1%, with equivalent admissions up 2.4%, supporting revenue growth, and the company raised its 2025 revenue guidance to between $75 billion and $76.5 billion, with expected earnings per share of $27.00 to $28.00. CEO Sam Hazen highlighted ongoing efforts to improve patient care through increased access, advanced technology investments, and staff training, while operational metrics such as quality and stakeholder satisfaction showed improvement. HCA's balance sheet as of September 30, 2025, included nearly $1 billion in cash and cash equivalents, $44.5 billion in total debt, and $59.7 billion in total assets, with capital expenditures for the year estimated at about $5 billion. Additionally, the Board declared a quarterly cash dividend of $0.72 per share to be paid in December 2025.